Zscaler, Inc. ZS Analyst Ratings

19 ratings from Wall Street analysts · Consensus as of Sep 3, 2026

Analyst Ratings
Buy Avg target $245 showing 19 ratings
Finviz analyst actions for ZS, accessed 3 September 2026: the latest attributable action per firm within the prior 12 months averages Buy with a $245.00 price target across 11 firms carrying targets. The sourced actions below are the full set Finviz exposed at capture time (https://finviz.com/quote.ashx?t=ZS). Consensus as of Sep 3, 2026
ZS
Upgrade
2026-06-01
Guggenheim
RatingBuy
FromNeutral
Target$214
From—
Reiterated
2026-05-27
BMO Capital Markets
RatingOutperform
From—
Target$178
From$210
Downgrade
2026-05-27
Evercore ISI
RatingIn-line
FromOutperform
Target$155
From—
Upgrade
2026-05-18
B. Riley Securities
RatingBuy
FromNeutral
Target$225
From—
Downgrade
2026-04-22
Morgan Stanley
RatingEqual-Weight
FromOverweight
Target$155
From—
Initiated
2026-03-03
Wells Fargo
RatingOverweight
From—
Target$200
From—
Reiterated
2026-02-27
BMO Capital Markets
RatingOutperform
From—
Target$210
From$315
Upgrade
2026-02-13
Bernstein
RatingOutperform
FromMkt Perform
Target$228
From—
Upgrade
2025-12-16
Mizuho
RatingOutperform
FromNeutral
Target$310
From—
Downgrade
2025-12-01
Bernstein
RatingMkt Perform
FromOutperform
Target$264
From—
Upgrade
2025-11-26
CapitalOne
RatingOverweight
FromEqual Weight
Target$320
From—
Reiterated
2025-11-26
Needham
RatingBuy
From—
Target$310
From$350
Initiated
2025-11-18
Berenberg
RatingBuy
From—
Target$400
From—
Reiterated
2025-09-03
BMO Capital Markets
RatingOutperform
From—
Target$315
From$295
Upgrade
2025-09-02
Morgan Stanley
RatingOverweight
FromEqual-Weight
Target$320
From—
Initiated
2025-08-26
B. Riley Securities
RatingNeutral
From—
Target$275
From—
Upgrade
2025-06-13
Wells Fargo
RatingOverweight
FromEqual Weight
Target$385
From—
Downgrade
2025-05-30
Piper Sandler
RatingNeutral
FromOverweight
Target$260
From—
Upgrade
2025-04-28
Exane BNP Paribas
RatingOutperform
FromNeutral
Target$260
From—